Schizoaffective Disorder News and Research

RSS
Virtual human helps veterans with PTSD, people with mental illness build job interview skills

Virtual human helps veterans with PTSD, people with mental illness build job interview skills

New study finds that some immigrants, refugees in Ontario at higher risk of psychotic disorders

New study finds that some immigrants, refugees in Ontario at higher risk of psychotic disorders

TSRI scientists find molecular trigger of schizophrenia-like behaviors and brain changes

TSRI scientists find molecular trigger of schizophrenia-like behaviors and brain changes

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

CET ‘feasible’ in schizophrenia patients with substance misuse

CET ‘feasible’ in schizophrenia patients with substance misuse

Health promotion program reduces cardiovascular risk in obese people with serious mental illness

Health promotion program reduces cardiovascular risk in obese people with serious mental illness

UM researchers develop novel, family-focused, culturally-informed treatment for schizophrenia

UM researchers develop novel, family-focused, culturally-informed treatment for schizophrenia

Accumulated environmental risks have substantial impact on schizophrenia

Accumulated environmental risks have substantial impact on schizophrenia

People with severe mental illness use YouTube to provide, receive peer support

People with severe mental illness use YouTube to provide, receive peer support

Longer looks: A new kind of abortion war; foster kids and psychotropic drugs

Longer looks: A new kind of abortion war; foster kids and psychotropic drugs

Impaired emotion recognition runs in families with psychosis

Impaired emotion recognition runs in families with psychosis

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Maternal inflammatory marker linked to children’s schizophrenia risk

Maternal inflammatory marker linked to children’s schizophrenia risk

Brain structure linked to psychosis symptoms

Brain structure linked to psychosis symptoms

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

Little efficacy difference between old and new antipsychotics

Little efficacy difference between old and new antipsychotics

Hippocampal role in psychosis bolstered

Hippocampal role in psychosis bolstered

Reduced rheumatoid arthritis risk in schizophrenia linked to underreporting

Reduced rheumatoid arthritis risk in schizophrenia linked to underreporting

Further support for hippocampal volume as psychosis biomarker

Further support for hippocampal volume as psychosis biomarker

Substance abuse worsens course of first-episode psychosis

Substance abuse worsens course of first-episode psychosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.